Bollard Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Buy
60,481
+4,758
+9% +$1.11M 0.47% 36
2026
Q1
$13.6M Buy
55,723
+5,790
+12% +$1.35M 0.4% 37
2025
Q4
$10.3M Sell
49,933
-22,913
-31% -$4.53M 0.26% 39
2025
Q3
$13.5M Buy
72,846
+3,665
+5% +$628K 0.32% 39
2025
Q2
$10.6M Buy
69,181
+5,101
+8% +$784K 0.24% 41
2025
Q1
$10.6M Buy
64,080
+446
+0.7% +$69.8K 0.28% 34
2024
Q4
$9.2M Sell
63,634
-12,836
-17% -$1.99M 0.26% 33
2024
Q3
$12.4M Sell
76,470
-12,726
-14% -$2.03M 0.33% 30
2024
Q2
$13M Buy
89,196
+4,688
+6% +$697K 0.37% 30
2024
Q1
$13.4M Buy
84,508
+1,402
+2% +$223K 0.4% 30
2023
Q4
$13M Sell
83,106
-15,157
-15% -$2.32M 0.45% 28
2023
Q3
$15.3M Buy
98,263
+679
+0.7% +$112K 0.56% 27
2023
Q2
$16.2M Buy
97,584
+759
+0.8% +$123K 0.55% 28
2023
Q1
$15M Buy
96,825
+655
+0.7% +$106K 0.54% 30
2022
Q4
$17M Sell
96,170
-381
-0.4% -$65.8K 0.65% 26
2022
Q3
$15.8M Buy
96,551
+75
+0.1% +$12.7K 0.66% 22
2022
Q2
$17.1M Buy
96,476
+569
+0.6% +$101K 0.69% 23
2022
Q1
$17M Sell
95,907
-5,343
-5% -$909K 0.54% 30
2021
Q4
$17.3M Buy
101,250
+22
+0% +$3.6K 0.55% 33
2021
Q3
$16.3M Buy
101,228
+6,038
+6% +$1.03M 0.54% 33
2021
Q2
$15.7M Buy
95,190
+5,263
+6% +$871K 0.5% 31
2021
Q1
$14.8M Buy
89,927
+459
+0.5% +$74.3K 0.52% 29
2020
Q4
$14.1M Sell
89,468
-1,069
-1% -$158K 0.52% 33
2020
Q3
$13.5M Buy
90,537
+397
+0.4% +$58.7K 0.49% 32
2020
Q2
$12.7M Sell
90,140
-7,665
-8% -$1.12M 0.5% 30
2020
Q1
$12.8M Buy
97,805
+5,700
+6% +$809K 0.57% 32
2019
Q4
$13.4M Buy
92,105
+3,394
+4% +$460K 0.44% 37
2019
Q3
$11.5M Buy
88,711
+31,008
+54% +$4.09M 0.4% 43
2019
Q2
$8.04M Buy
57,703
+13,273
+30% +$1.84M 0.28% 52
2019
Q1
$6.21M Buy
44,430
+25,142
+130% +$3.37M 0.23% 57
2018
Q4
$2.49M Buy
19,288
+1,295
+7% +$181K 0.11% 92
2018
Q3
$2.49M Buy
17,993
+3,591
+25% +$477K 0.1% 97
2018
Q2
$1.75M Buy
14,402
+1,649
+13% +$206K 0.08% 109
2018
Q1
$1.63M Buy
12,753
+1,874
+17% +$253K 0.08% 113
2017
Q4
$1.52M Buy
10,879
+465
+4% +$64.8K 0.07% 113
2017
Q3
$1.35M Buy
10,414
+863
+9% +$114K 0.07% 121
2017
Q2
$1.26M Buy
9,551
+459
+5% +$58.6K 0.07% 127
2017
Q1
$1.13M Buy
9,092
+759
+9% +$90.7K 0.06% 133
2016
Q4
$960K Buy
8,333
+3,935
+89% +$455K 0.06% 139
2016
Q3
$520K Buy
4,398
+503
+13% +$61K 0.03% 154
2016
Q2
$473K Buy
3,895
+27
+0.7% +$3.07K 0.03% 157
2016
Q1
$419K Buy
3,868
+27
+0.7% +$2.79K 0.03% 156
2015
Q4
$395K Buy
3,841
+28
+0.7% +$2.82K 0.03% 158
2015
Q3
$356K Buy
3,813
+2,031
+114% +$196K 0.03% 173
2015
Q2
$174K Buy
1,782
+11
+0.6% +$1.1K 0.01% 199
2015
Q1
$178K Buy
1,771
+11
+0.6% +$1.12K 0.01% 198
2014
Q4
$184K Buy
1,760
+10
+0.6% +$1.05K 0.02% 186
2014
Q3
$187K Buy
1,750
+10
+0.6% +$1.04K 0.02% 202
2014
Q2
$182K Hold
1,740
0.02% 198
2014
Q1
$171K Hold
1,740
0.02% 197
2013
Q4
$159K Sell
1,740
-8,500
-83% -$783K 0.02% 187
2013
Q3
$888K Hold
10,240
0.1% 99
2013
Q2
$879K Buy
+10,240
New +$869K 0.17% 75

Other funds holding JNJ

Bollard Group's JNJ Position: Q2 2026 in Review

Bollard Group increased its Johnson & Johnson (JNJ) stake by 8.5% in Q2 2026, buying an estimated $1.11M and bringing the position to 60,481 shares worth $15.4M. The position accounts for 0.47% of the portfolio, ranked #36.

Bollard Group first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.3M in Q4 2021. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bollard Group held 60,481 shares of Johnson & Johnson worth $15.4M as of Q2 2026.
  • Bollard Group bought 4,758 Johnson & Johnson shares in Q2 2026, an estimated $1.11M.
  • Johnson & Johnson made up 0.47% of Bollard Group's portfolio in Q2 2026, its #36 holding.
  • Bollard Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Bollard Group's Johnson & Johnson position peaked at $17.3M in Q4 2021.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.